<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00799838</url>
  </required_header>
  <id_info>
    <org_study_id>KETOP_L_03102</org_study_id>
    <secondary_id>2014-004002-15</secondary_id>
    <nct_id>NCT00799838</nct_id>
  </id_info>
  <brief_title>Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal Tonsillitis in Pediatric Patients</brief_title>
  <acronym>DROPS</acronym>
  <official_title>Local, Phase IV, Multicenter, Double-blind, Randomized, Parallel, With Two Treatment Arms, Placebo-controlled Study to Evaluate the Reduction of Inflammatory Symptoms in the Treatment of Bacterial Pharyngitis With Ketoprofen and Amoxicillin in Pediatric Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanofi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the inflammatory symptoms and signs (hyperemia,
      edema and pain) reduction after 24 hours of treatment with ketoprofen drops when associated
      to amoxicillin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The total duration of the study period per patient is 10 Â± 1 day
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Recruitment challenges despite several attenpts to increase enrollment
  </why_stopped>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with reduction of inflammatory signs and symptoms after 24 hours of treatment</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with reduction of inflammatory signs and symptoms after 72 hours of treatment</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with reduction of inflammatory signs and symptoms with no use of rescue medication</measure>
    <time_frame>24 hours and 72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients who used rescue medication after randomization.</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">106</enrollment>
  <condition>Pharyngotonsillitis</condition>
  <arm_group>
    <arm_group_label>Ketoprofen + Amoxicillin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketoprofen + Amoxicillin for 3 days, then Amoxicillin alone for 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Amoxicillin</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (for ketoprofen) + Amoxicillin for 3 days, then Amoxicillin alone for 7 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketoprofen</intervention_name>
    <description>Formulation: oral solution 20mg/mL
Route of administration: oral
Dose regimen: 1 drop/Kg for children aged between 4 to 6 years old or 25 drops for children from 7 to 11 years old administered t.i.d</description>
    <arm_group_label>Ketoprofen + Amoxicillin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (for Ketoprofen)</intervention_name>
    <description>Formulation: oral solution
Route of administration: oral
Dose regimen: 1 drop/Kg for children aged between 4 to 6 years old or 25 drops for children from 7 to 11 years old administered t.i.d</description>
    <arm_group_label>Amoxicillin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin</intervention_name>
    <description>Formulation: suspension 125mg/5 mL
Route of administration: oral
Dose regimen: 20-40mg/Kg/day administered t.i.d</description>
    <arm_group_label>Ketoprofen + Amoxicillin</arm_group_label>
    <arm_group_label>Amoxicillin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Quick-test positive for Streptococcus pyogenes;

          -  Indication for treatment with amoxicillin according to labeling and physician's
             clinical evaluation;

          -  Pain (for swallowing) evaluated by Wong Baker Faces Pain scale with at least grade 3;

          -  Presence of at least two of the follow symptoms:

               -  Hyperemia and edema evaluated with at least 2 out of 4 crosses

               -  Fever in the previous 48 hours

               -  Cervical adenomegaly

               -  Tonsilla with erythema or erythema and white exsudate.

        Exclusion Criteria:

          -  History of cardiovascular, gastrointestinal, metabolic or psychiatric conditions;

          -  History and laboratorial confirmation of hematologic, hepatic or renal disorders;

          -  Use of nonsteroidal antiinflammatory drugs (NSAID) during the last 3 weeks and
             gastroesophageal reflux during the last 6 months;

          -  Use of analgesic or anti inflammatory medication (except Paracetamol) in the previous
             12 hours;

          -  History of allergy or hypersensitivity to amoxicillin and/ or ketoprofen.

        The above information is not intended to contain all considerations relevant to a patient's
        potential participation in a clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaderson Lima, MD</last_name>
    <role>Study Director</role>
    <affiliation>Sanofi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2008</study_first_submitted>
  <study_first_submitted_qc>November 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2008</study_first_posted>
  <last_update_submitted>October 23, 2014</last_update_submitted>
  <last_update_submitted_qc>October 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Ketoprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

